Cargando…
PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer
The standard care for patients with locally advanced cervical cancer is concurrent chemoradiotherapy. Successful neoadjuvant chemotherapy (NAC) can reduce tumor size and enable patients to be eligible for a hysterectomy, which can improve their prognosis. Selecting the right candidate for NAC is imp...
Autores principales: | Shimomura, Masahiro, Fukuda, Takeshi, Awazu, Yuichiro, Nanno, Shigenori, Inoue, Yuta, Matsubara, Hiroaki, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798043/ https://www.ncbi.nlm.nih.gov/pubmed/33552268 http://dx.doi.org/10.3892/ol.2020.12411 |
Ejemplares similares
-
T-box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma
por: Inoue, Yuta, et al.
Publicado: (2021) -
Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy
por: Nanno, Shigenori, et al.
Publicado: (2022) -
Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma
por: Fukuda, Takeshi, et al.
Publicado: (2021) -
CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy
por: Awazu, Yuichiro, et al.
Publicado: (2023) -
Uterine metastasis of lobular breast carcinoma under tamoxifen therapy: A case report
por: Awazu, Yuichiro, et al.
Publicado: (2021)